These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31045658)

  • 41. Early atherosclerosis aggravates renal microvascular loss and fibrosis in swine renal artery stenosis.
    Sun D; Eirin A; Ebrahimi B; Textor SC; Lerman A; Lerman LO
    J Am Soc Hypertens; 2016 Apr; 10(4):325-35. PubMed ID: 26879682
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal artery revascularization: outcomes stratified by indication for intervention.
    Patel VI; Conrad MF; Kwolek CJ; LaMuraglia GM; Chung TK; Cambria RP
    J Vasc Surg; 2009 Jun; 49(6):1480-9. PubMed ID: 19497511
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Understanding and managing atherosclerotic renovascular disease: still a work in progress.
    Chade AR
    F1000Res; 2018; 7():. PubMed ID: 30631430
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of acute and chronic antioxidant interventions in experimental renovascular disease.
    Chade AR; Krier JD; Rodriguez-Porcel M; Breen JF; McKusick MA; Lerman A; Lerman LO
    Am J Physiol Renal Physiol; 2004 Jun; 286(6):F1079-86. PubMed ID: 14722019
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of atherosclerotic renal artery stenosis: time for a new approach.
    de Leeuw PW; Postma CT; Kroon AA
    JAMA; 2013 Feb; 309(7):663-4. PubMed ID: 23423409
    [No Abstract]   [Full Text] [Related]  

  • 46. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period.
    Mousa AY; Campbell JE; Stone PA; Broce M; Bates MC; AbuRahma AF
    J Vasc Surg; 2012 Feb; 55(2):421-7. PubMed ID: 22112553
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current Status of Renal Artery Angioplasty and Stenting for Resistant Hypertension: A Case Series and Review of the Literature.
    Manolis AS; Manolis AA; Melita H
    Curr Hypertens Rev; 2017; 13(2):93-103. PubMed ID: 28782466
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal revascularization for hypertension with azotemia.
    N Engl J Med; 1985 Apr; 312(17):1124-5. PubMed ID: 3157058
    [No Abstract]   [Full Text] [Related]  

  • 49. Update on the management of atherosclerotic renal artery disease.
    Fenstad ER; Kane GC
    Minerva Cardioangiol; 2009 Feb; 57(1):95-101. PubMed ID: 19202521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence-based medicine in renal artery stenting.
    Rabbia C; Pini R
    J Cardiovasc Surg (Torino); 2010 Oct; 51(5):755-63. PubMed ID: 20924335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of renal revascularization on the development of renal dysfunction in atherosclerotic ischemic nephropathy.
    Hagemann R; Silva Vdos S; Franco RJ; Barretti P; Martin LC
    J Bras Nefrol; 2014; 36(4):535-41. PubMed ID: 25517284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Geriatric hypertension of renovascular origin: diagnosis and management.
    Vidt DG
    Geriatrics; 1987 Jul; 42(7):59-70. PubMed ID: 2954883
    [TBL] [Abstract][Full Text] [Related]  

  • 53. With a Little Help From My Friends: the Role of the Renal Collateral Circulation in Atherosclerotic Renovascular Disease.
    Nyvad J; Lerman A; Lerman LO
    Hypertension; 2022 Apr; 79(4):717-725. PubMed ID: 35135307
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization.
    Ritchie J; Green D; Chrysochou C; Chalmers N; Foley RN; Kalra PA
    Am J Kidney Dis; 2014 Feb; 63(2):186-97. PubMed ID: 24074824
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atherosclerotic renovascular disease in chronic heart failure: should we intervene?
    de Silva R; Nikitin NP; Bhandari S; Nicholson A; Clark AL; Cleland JG
    Eur Heart J; 2005 Aug; 26(16):1596-605. PubMed ID: 15919719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Renovascular hypertension: diagnostic and therapeutic challenges.
    Bosmans JL; De Broe ME
    JBR-BTR; 2004; 87(1):32-5. PubMed ID: 15055332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Controversies in renal artery stenosis: a review by the American Society of Nephrology Advisory Group on Hypertension.
    Levin A; Linas S; Luft FC; Chapman AB; Textor S;
    Am J Nephrol; 2007; 27(2):212-20. PubMed ID: 17377375
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stenting for atherosclerotic renal artery stenosis.
    Carr TM; Sabri SS; Turba UC; Park AW; Saad WE; Angle JF; Matsumoto AH
    Tech Vasc Interv Radiol; 2010 Jun; 13(2):134-45. PubMed ID: 20540922
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimal medical management in patients with renovascular hypertension.
    Balafa O; Kalaitzidis R; Siamopoulos KC
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):71-8. PubMed ID: 23494905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical utility of the resistive index in atherosclerotic renovascular disease.
    Crutchley TA; Pearce JD; Craven TE; Stafford JM; Edwards MS; Hansen KJ
    J Vasc Surg; 2009 Jan; 49(1):148-55, 155.e1-3; discussion 155. PubMed ID: 18951751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.